Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCNEL.L Regulatory News (CNEL)

  • There is currently no data for CNEL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

19 Sep 2017 07:00

RNS Number : 0971R
China New Energy Ltd
19 September 2017
 

19 September 2017

 

China New Energy Limited

("China New Energy" "CNE" or "the Group")

 

 

 

Half-yearly report for the six months to 30 June 2017

 

China New Energy Limited (AIM: CNEL), the engineering and technology solutions provider to the bioenergy sector, announces its unaudited half-yearly results for the six months ended 30 June 2017.

 

Financial Highlights

· Revenue of RMB 68.76m (£7.73m) (H1 2016: RMB 45.4m (£5.11m)), which represents a 51% increase over the same period last year

· Gross profit of RMB 16.6m (£1.87m) (H1 2016: RMB 16.2m (£1.82m))

· Net Profit of RMB 10.6m (£1.19m) (H1 2016: RMB 11.3m (£1.27m))

· Earnings per share of RMB 0.023 (0.26p) (H1 2016 RMB 0.029 (0.33p))

 

RMB8.89: GBP £1 used as an indicative exchange rate.

 

 

Yu Weijun, Chairman, commented:

 

"I am very pleased to report that, based on contracts from China, the Company has had its third successive profitable half year and is demonstrating a return to sustained profitability. The bioenergy industry still faces many headwinds due to the low-oil price, however, regulatory changes are helping drive our domestic business. The company has a current order book and work in progress of RMB 255 million (c. £28.7m) to be fulfilled in 2017/18, and I am optimistic that the business outlook is for sustained revenue growth.

 

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

Enquiries:

 

China New Energy Limited

www.chinanewenergy.co.uk

Richard Bennett

Tel: +44 (0)20 7148 3148 or rbennett@zkty.com.cn

Nick Brooks

Tel: +44 (0) 7920 060218 or nbrooks@zkty.com.cn

Derek Cen

Tel: +86 (0)20 8705 8986 or cendl@zkty.com.cn

 

 

Cairn Financial Advisers LLP (NOMAD)

Tel: +44 20 7213 0880

Jo Turner / Sandy Jamieson

 

 

 

Daniel Stewart and Co (Broker)

Tel: +44 20 7776 6550

David Lawman

 

 

 

 

Chairman's Statement

 

 

On behalf of the Board, I am very pleased to present the unaudited half-yearly results for the six months period ended 30 June 2017.

 

Financial Review

 

Revenue for the first six months of the year has grown to RMB 68.76m (H1 2016: RMB 45.4m), an increase of approximately 51%. A significant driver of the increase in revenue was the change of rules pertaining to the types of feedstock that may be used to produce ethanol in China, which stimulated new orders from existing clients including Jilin Boda and COFCO. The Company's order book is currently RMB 255m of which RMB 41m is carried forward from 2016 and the remainder is new orders in H1 2017 that are expected to be fulfilled in 2017 and 2018.

 

The Group's gross profit also increased in the period to RMB 16.6m (H1 2016: RMB 16.2m) which resulted in the Group returning a net profit in the period of RMB 10.6m (H1 2016: RMB 11.3m). The gross margin has decreased to 24.1% from 35.8%, which the board believes is temporary and specifically relates to competitive bidding on the COFCO contract.

 

Selling and distribution expenses increased by 30% to RMB 3.1m (H1 2016: RMB 2.39m) while administrative expenses decreased by 47% to RMB 2.5m (H1 2016: RMB 4.76m). The Group's other income was RMB 0.7m (H1 2016: RMB 2.89m). The other expenses were RMB 0.68m (H1 2016: RMB 0.55m). Finance expense increased to RMB 0.4m (H1 2016: RMB 0.14m).

 

Operational Review

CNE is a market leader in China at designing and building biorefineries that convert agricultural feedstock such as corn, cassava and sugarcane into ethanol. We have completed more than 180 projects in China and around the world. The Group principally provides EPC (Equipment, Procurement and Construction) services and VAS (Value Added Service) to ethanol and biobutanol producers. The EPC team primarily designs and builds commercial-scale biorefineries that convert feedstock into ethanol for both the biofuel and edible alcohol markets, whilst the VAS team provide services and technology to optimise the ethanol production at existing biorefineries.

 

As a result of recent policy changes that allows approximately 300 million tonnes of accumulated agricultural feedstocks to be converted to ethanol and animal feed, China currently represents the largest potential market for the Group. This provides an immediate opportunity for alcohol and fuel ethanol producers to increase their production capacity and expand their production. As a leading provider of bioenergy technology in China, the Group expects to bid for more upcoming contracts with existing clients and domestic ethanol producers including COFCO Group, Jilin Boda Biochemical Company, Inner Mongolia Liniu Biochemical Group.

 

To meet this market growth, during the first half of the year the Group recruited more than 20 technicians and engineers to fulfil the current and anticipated future orders.

 

The Group's strategy remains to diversify into international markets. However, progress is slower than anticipated including contracts already won and most, notably, the Group is still awaiting a project start date from the Supercare Group in Ghana. Elsewhere in sub-Sharan Africa, Sunbird Bioenergy Africa ("Sunbird") continues to make progress with their projects and reaffirmed their commitment to developing an ethanol project in Zambia at the Luapula Investment Conference in July. CNE remains optimistic about tendering for the ethanol distillery and associated plant in due course, and will update the market as contractual developments take place.

 

 

Corporate Development.

 

With the return to profitability, the Directors are reviewing a number of initiatives to support the continued growth of the Group and the value created is reflected in the share price. These include:

· Implementing a share option scheme to attract, retain and motivate new and current employees

· Strategic acquisitions

· Requesting shareholder permission by way of an EGM to use free cash for a share buy-back program

 

 

Outlook

 

After the downturn in the bioenergy market in the past few years, we are beginning to see an increased demand for our products and services. This is attributed to the economic recovery in the industry and the change of rules pertaining to ethanol feedstock usage in China.

 

China remains an important participant in the global energy market and is very focussed on delivering renewable energy to both reduce emissions and increase energy security and reliance on importing fossil fuels. We note the country recently signed the Paris Climate Change Agreement, and also announced its intention to rollout a national ethanol-fuel blending (E10) program. Ethanol is widely considered to be one of the key alternatives to fossil fuel and a pathway to lower emissions.

 

The company intends to continue its research and development activities in partnership with institutions including Guangzhou Institute of Energy Conversion ("GIEC"), part of the Chinese Academy of Sciences, to commercialise advanced alternative and renewable energy technologies for the bioenergy market.

 

Internationally, we continue to promote our products and services through our partners. We continue to see an interest in our existing 1st generation bioenergy technology in emerging markets such as Africa and South East Asia. We also see an increased interest in 2nd generation bioenergy technology in developed markets which is also being aided by changes in the regulatory environment to support biofuel production.

 

The Board are very pleased with our current progress and profitability. The board is also confident about the increased interest in the bioenergy sector and our pipeline of sales opportunities. However, we continue to maintain a cautious business approach due to the macro-economic climate and continued low-oil prices.

 

 

Yu Weijun

Chairman

 

19 September 2017

 

Consolidated Statement of Financial Position

 

 

Unaudited

 

Unaudited

 

Audited

Six months to 30 June

 

Six months to 30 June

 

Year to 31 December

 

 

2017

 

2016

 

2016

 

Note

RMB'000

 

RMB'000

 

RMB'000

Non-current assets

 

 

 

 

 

 

Property, plant and equipment

 

3,905

 

4,921

 

4,774

Intangible assets

 

14,858

 

12,107

 

14,541

Trade receivables

 

 

 

 

 

 

Investments in subsidiaries

 

 

 

 

 

 

 

 

18,763

 

17,028

 

19,315

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

Inventories

 

8,527

 

7,576

 

3,438

Due from customers for construction contracts

 

52,703

 

29,796

 

35,713

Trade and other receivables

 

154,201

 

97,524

 

73,217

Notes receivables

 

 

 

 

 

 

Cash and cash equivalents

 

12,917

 

19,918

 

13,854

 

 

228,348

 

154,814

 

126,222

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

Trade and other payables

 

128,923

 

104,143

 

91,976

Due to customers for construction contracts

 

88,107

 

46,777

 

30,215

Provision for liabilities

 

 

 

 

 

10,000

Income tax payable

 

8,797

 

8,783

 

8,776

Short-term borrowing

 

 

 

 

 

 

 

 

225,827

 

159,703

 

140,967

 

 

 

 

 

 

 

Net current assets/(liabilities)

 

2,521

 

(4,922)

 

(14,745)

 

 

 

 

 

 

 

Non-current liabilities

 

 

 

 

 

 

Deferred tax liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net assets

 

21,284

 

12,106

 

4,570

 

 

 

 

 

 

 

Equity

 

 

 

 

 

 

Share Capital

3

1,541

 

1,445

 

1,441

Share premium

 

68,805

 

63,208

 

62,905

Combination reserve

 

(33,156)

 

(33,156)

 

(33,156)

Warrants reserve

 

 

 

1,673

 

 

Statutory reserve

 

12,328

 

12,328

 

12,328

Convertible bonds reserve

 

 

 

 

 

 

Own shares

 

 

 

 

 

 

Accumulated earnings/(losses)

 

(52,458)

 

(57,028)

 

(63,039)

Foreign currency translation reserve

 

24,224

 

23,636

 

24,091

 

 

21,284

 

12,106

 

4,570

 

 

 

Consolidated Statement of Comprehensive Income

 

 

 

Unaudited

 

Unaudited

 

Audited

Six months to 30 June 2017

 

Six months to 30 June 2016

 

Year to 31 December 2016

 

Note

RMB'000

 

RMB'000

 

RMB'000

 

 

 

 

 

 

 

Revenue

 

68,760

 

45,369

 

78,584

Cost of sales

 

(52,191)

 

(29,123)

 

51,586

 

 

 

 

 

 

 

Gross profit/(loss)

 

16,569

 

16,246

 

26,998

 

 

 

 

 

 

 

Other operating income

 

732

 

2,888

 

3,204

Selling and distribution expenses

 

(3,100)

 

(2,391)

 

(4,868)

Administrative expenses

 

(2,539)

 

(4,756)

 

(7,576)

Other operating expenses

 

(676)

 

(554)

 

(9,696)

Finance expenses

 

(403)

 

(138)

 

(1,494)

Bad debt provision(net)

 

(2)

 

 

 

(2,715)

Impairment loss

 

 

 

 

 

(242)

Other gains and losses

 

 

 

 

 

 

 

 

 

 

 

 

 

(Loss)/ Profit before income tax

 

 

 

 

 

 

10,581

 

11,295

 

3,611

Income tax expense

 

 

 

 

 

 

Deferred tax expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

(Loss)/Profit for the financial period

 

10,581

 

11,295

 

3,611

 

 

 

 

 

 

 

Other comprehensive income:

 

 

 

 

 

 

Exchange difference

 

133

 

189

 

405

 

 

10,714

 

11,484

 

4,106

Total comprehensive income for the financial year

 

 

 

 

10,714

 

11,484

 

4,106

Total comprehensive income attributable to equity holder

 

 

 

 

 

 

 

 

 

Earnings/(loss) per share (RMB):

 

 

 

 

 

 

Basic

6

0.023

 

0.029

 

0.009

Diluted

6

0.023

 

0.029

 

0.009

 

 

 

 

 

 

 

 

 

 

Consolidated Statement of Cash flows

 

 

 

Unaudited

 

Unaudited

 

Audited

Six months to 30 June

 

Six months to 30 June

 

Year to 31 December

 

 

2017

 

2016

 

2016

 

 

RMB'000

 

RMB'000

 

RMB'000

 

 

 

 

 

 

 

Operating activities

 

 

 

 

 

 

Profit/(loss) before income tax

 

10,581

 

11,295

 

3,611

Adjustments for:

 

 

 

 

 

 

Depreciation and amortisation

 

(1,272)

 

(349)

 

2,565

 

Bad debt provision(net)

 

 

 

 

 

 

Loss/(gain) on disposal of property, plant and equipment

 

 

 

(26)

 

1,548

Loss/(gain) on disposal of financial assets

 

 

 

 

 

(2,359)

Interest income

 

(27)

 

(27)

 

(55)

Finance expense

 

535

 

562

 

537

Impairment loss

 

 

 

 

 

(124)

Exchange difference

 

(133)

 

(50)

 

405

Operating cash flows before movements in working capital

 

 

 

12,521

 

11,405

 

6,128

 

 

 

 

 

 

 

Decrease/(increase) in inventories

 

(5,089)

 

2,362

 

6,258

Construction work-in-progress

 

(16,990)

 

19,211

 

(5,473)

Trade and other receivables

 

(80,984)

 

(54,372)

 

(23,745)

Notes receivables

 

 

 

444

 

 

Trade and other payables

 

26,947

 

13,986

 

8,466

Decrease/(increase) in due to

customers for construction

 

 

57,892

 

 

 

 

2,649

 

Cash generated from/(used in) operations

 

 

(5,703)

 

 

(6,964)

 

 

5,717

Income taxes paid

 

21

 

7

 

 

Dividend received

 

 

 

 

 

 

Net cash from/(used in) operating activities

 

(5,682)

 

(6,957)

 

5,717

 

 

 

 

 

 

 

Investing activities

 

 

 

 

 

 

Proceeds from disposal of property, plant and equipment

 

 

 

 

 

Purchase of property, plant and equipment

(139)

 

1,694

 

(1,965)

Expenditure on intangible assets

 

(581)

 

(310)

 

(3,701)

 

Net cash from/(used in) investing activities

(720)

 

1,384

 

(5,666)

 

 

 

 

 

Financing activities

 

 

 

 

 

Short-term borrowing

 

 

 

 

 

Repayment of borrowings

 

 

 

 

 

Proceeds from issuance of shares

6,000

 

6,600 

 

6,293

Redemption of convertible bonds

 

 

 -

 

 

Interest received

 

 

27

 

55

Interest paid

 

(535)

 

(562)

 

(537)

 

 

 

 

 

 

Net cash from/(used in) financing activities

5,465

 

6,065

 

(5,811)

 

 

 

 

 

Net increase/(decrease) in cash and cash equivalents

(937)

 

492

 

5,572

Cash and bank balances at beginning of period

13,854

 

19,426

 

19,426

Effect of foreign exchange rate changes in cash and bank balances

 

 

 

 

 

Cash and cash equivalents at end of period

12,917

 

19,918

 

13,854

 

Consolidated Statement of Changes in Equity

 

 

Share capital

 

Share premium

 

Combination

 

Statutory reserve

 

Warrants reserve

 

Own shares

 

Accumulated earnings/ (losses)

 

Foreign currency translation reserve

 

Total

 
 

 

 

RMB'000

 

RMB'000

 

RMB'000

 

RMB'000

 

 

 

 

 

RMB'000

 

RMB'000

 

RMB'000

 

Balance at 31 December 2015

 

1,357

 

56,696

 

(33,156)

 

12,328

 

1,673

 

 

 

(68,323)

 

23,686

 

(5,739)

 

Profit for the period

 

-

 

-

 

-

 

-

 

-

 

-

 

3,611

 

 

 

3,611

 

Exchange difference arising on the translation

 

-

 

-

 

-

 

-

 

-

 

-

 

 

 

405

 

405

 

Transfer warrant reserve

 

 

 

 

 

 

 

 

 

(1,673)

 

 

 

1,673

 

 

 

 

 

Total comprehensive income for the period

 

-

 

-

 

-

 

-

 

(1,673)

 

-

 

5,284

 

405

 

4,016

 

Issue of shares, net of share issue costs

 

84

 

6,209

 

 

 

 

 

 

 

 

 

 

 

 

 

6,293

 

Shares granted to

Cancellation of EBT

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at Dec. 2016

 

1,441

 

62,905

 

-33,156

 

12,328

 

 

 

 

 

(63,039)

 

24,091

 

4,570

 

Profit for the period

 

-

 

-

 

-

 

-

 

-

 

-

 

10,581

 

 

 

10,581

 

Exchange difference arising on the translation

 

-

 

-

 

-

 

-

 

-

 

-

 

 

 

133

 

133

 

Total comprehensive income for the period

 

-

 

-

 

-

 

-

 

-

 

-

 

10,581

 

133

 

10,714

 

Issue of warrants

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

-

 

Issue of shares, net of share issue costs

 

100

 

5,900

 

 

 

 

 

 

 

 

 

 

 

-

 

6,000

 

Transfer to statutory reserve

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

-

 

Balance at 30 June 2017

 

1,445

 

63,208

 

-33,156

 

12,328

 

1,673

 

 

 

(57,028)

 

23,636

 

21,284

 

 

 

 

Notes to the Interim Financial Information - Period ended 30 June 2017

 

1. General information

The Group (or "CNE") with registration number 93306 was incorporated in Jersey on 2 May 2006 as an investment holding Group. The Group is domiciled in Jersey with its registered office at Queensway House, Hilgrove Street, St Helier, Jersey JE1 1ES.

 

The principal activities of its main subsidiary, Guangdong Zhongke Tianyuan New Energy Science and Technology Co Ltd. ("ZKTY") are engaged in turnkey technology solutions to manufacturers of ethanol, edible alcohol and acetic acid from a range of bio-resources including corn, sugarcane, cassava and other bio-resources.

The principal place of business is located at No 4, Nengyuan Road, Wushan, Tianhe District, Guangzhou, People's Republic of China ("PRC").

 

2. Basis of preparation

 

The financial statements have been prepared in accordance with the International Financial Reporting Standards (IFRS) as adopted by the European Union. The principal accounting policies used in preparing the interim results are those the Group expects to apply in its financial statements for the year ending 31 December 2017 and are unchanged from those disclosed in the Group's Report and Financial Statements for the year ended 31 December 2016, except for the following additional accounting policies:

 

Basis of consolidation

The Group includes the assets and liabilities of the Employee Benefit Trust ("EBT") within its Statement of Financial Position. In the event of the winding up of the Group, neither the shareholders nor the creditors would be entitled to the assets of the EBT.

 

Long-term incentive scheme charge

The fair value of the employee services received in exchange for the grant of shares or share options is recognised as an expense.

 

The total amount to be expensed over the performance period, from grant date to vesting date, is determined by reference to the fair value of the shares determined at the date the employee is deemed to be fully aware of their potential entitlement and all conditions of vesting.

 

Own shares

Company shares held by the EBT are deducted from the shareholders' funds and classified as Own Shares until such time as they vest unconditionally to participating employees and their families.

 

This interim financial information has not been reviewed or audited by the Group's auditors. The comparatives for the period ended 31 December 2016 are not the Group's full statutory accounts for that period but have been extracted from those financial statements. A copy of the statutory financial statements for that period, which were prepared under IFRS, has been delivered to the Companies Registry. The auditors' report on those accounts was unqualified.

 

Whilst the financial information included in this Interim Financial information has been prepared in accordance with the recognition and measurement criteria of IFRS, it does not include sufficient information to comply with IFRS.

 

This interim report was approved by the Board of directors on 19 September 2017.

 

 

3. Ordinary shares

 

 

 

 Number of Shares

 Share Capital

 Share premium

 

 

 £ '000

 RMB '000

 £ '000

 RMB '000

As at 30 December 2016

444,447,541

 

1,445

 

63,208

Placing on 22 March 2017

46,808,809

12

100

690

5,900

As at 30 June 2017

491,256,350

 

1,541

 

68,805

 

 

 

 

The substantial shareholders have not changed from 30 June 2017 we outlined in the annual report.The Group has one class of ordinary shares which carry no right to fixed income.

 

 

4. Property, plant and equipment

 

 

 

Plant and machinery

Motor Vehicles

Office equipment

Leasehold improvements

Total

 

 

RMB'000

RMB'000

RMB'000

RMB'000

RMB'000

As at 30 June 2017

 

 

 

 

 

 

 

Cost

 

 

 

 

 

 

 

At 1 January 2017

 

3,227

8,391

834

6,247

18,699

Additions

 

131

-

8

-

138

Disposals

 

-

 

-

 

 

 

 

 

 

 

 

At 30 June 2017

 

3,358

8,391

842

6,247

18,837

 

 

 

 

 

 

 

 

Accumulated depreciation

 

 

 

 

 

 

At 1 January 2017

 

2,803

6,901

604

3,617

13,925

Charged for the year

 

143

689

28

147

1,007

Disposals

 

-

 

-

-

 

 

 

 

 

 

 

 

At 30 June 2017

 

2,946

7,590

632

3,764

14,932

 

 

Carrying amount

 

 

 

 

 

 

At 1 January 2017

 

424

1,490

230

2,630

4,774

 

 

 

 

 

 

 

At 30 June 2017

 

412

801

209

2,483

3,905

 

 

5. Intangible assets

 

 

Computer software

Patents

Technology Knowhow

Land use management

Development cost

Total

 

RMB'000

RMB'000

RMB'000

RMB'000

RMB'000

RMB'000

 

 

 

 

 

 

 

Cost

 

 

 

 

 

 

Balance at beginning of year

60

6,936

 

3,613

5,865

16,474

Additions

-

581

-

-

581

Transfer

 

 

 

 

 

 

Balance at end of year

60

7,517

-

3,613

5,865

17,055

 

 

 

 

 

 

 

Accumulated amortisation

 

 

 

 

 

 

Balance at beginning of year

57

1,034

 

842

-

1,933

Amortisation for the year

(232)

-

(32)

(264)

Balance at end of year

57

1,266

-

874

2,197

 

Carrying amount

 

 

 

 

 

 

 

As at 31 Dec 2016

3

5,902

-

2,771

5,865

14,541

 

 

 

 

 

 

 

As at 30 June 2017

3

6,251

-

2,739

5,865

14,858

 

 

6. Earnings per share

 

Earnings per share ("EPS") on a basic and diluted basis are as follows:

 

Earnings per share ("EPS") on a basic and diluted basis are as follows:

 

Earnings

Weighted average number of shares

Earning per shares

Earnings

Weighted average number of shares

Earning per shares

 

Six months

Six months

Six months

Six months

Six months

Six months

 

to 30 June

to 30 June

to 30 June

to 30 June

to 30 June

to 30 June

 

2017

2017

2017

2016

2016

2016

 

Unaudited

Unaudited

Unaudited

Unaudited

Unaudited

Unaudited

 

RMB'000

RMB'000

RMB'000

RMB'000

RMB'000

RMB'000

Earnings/(loss)per share-basic

10,714

470,348,415

0.023

11,484

401,723,797

0.029

Potentially dilutive shares

-

-

-

-

 

-

Earnings/(loss)per share-diluted

10,714

470,348,415

0.023

11,484

401,723,797

0.029

 

 

7. Directors' interests

 

The following Directors have held office during the period and their interests as at 30 June 2017, all of which are beneficial unless otherwise stated, whether direct or indirect, of the Directors and their families in the issued share capital of the company and options over Ordinary Shares which had been granted, are as follows:

 

Director

 

Number of Ordinary Shares

 

Percentage of Ordinary Shares

Yu Weijun

 

90,932,440

 

18.51%

Tang Zhaoxing

 

48,000,000

 

9.77%

Nicholas Brooks

 

105,000

 

0.02%

Richard Bennett

 

-

 

-

 

8. Business Segment

 

A business segment is a Group of assets and operations engaged in providing products or services that are subject to risks and returns that are different from those of other business segments. A geographical segment is engaged in providing products or services within a particular economic environment that is subject to risks and returns that are different from those of segments operating in other economic environments. 

 

The Group's revenue breakdown by geographical location is determined based on its customers' country of incorporation. The Group's cost of sales and operating expenses are aggregated on a cumulative basis and are not attributable to specific geographical regions. Therefore, a breakdown of gross profit for the financial years by geographical regions is not shown.

 

 

Geographical Segment

 Revenue

6 months ended

 

30 June 2017

 

30 June 2016

 

 

RMB'000

 

RMB'000

 

 

 

 

 

 

PRC

66,986

 

37,167

 

Thailand

93

 

 

 

Canada

1,681

 

8,202

 

 

 

 

 

 

 

 

 

 

 

 

68,760

 

45,369

 

 

 

 

 

 

 

 

 

 

The CNE Group's assets, liabilities and capital expenditure are almost entirely attributable to a single business segment of provision of technology and engineering services to ethanol, ethanol downstream product and biobutanol producers. Therefore, the CNE Group does not have separately reportable business segments under IFRS 8 Segmental Reporting.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR DBGDCCDBBGRI
Date   Source Headline
14th Jul 20206:00 pmRNSChina New Energy
14th Jul 20204:49 pmRNSHKEx Admission and Cancellation of Trading on AIM
14th Jul 20202:05 pmRNSSecond Price Monitoring Extn
14th Jul 20202:00 pmRNSPrice Monitoring Extension
14th Jul 202011:06 amRNSSecond Price Monitoring Extn
14th Jul 202011:00 amRNSPrice Monitoring Extension
14th Jul 20207:00 amRNSGlobal Offering, Issue of Equity and HKEx update
30th Jun 20207:00 amRNSPublication of Prospectus and Global Offering
29th Jun 20204:40 pmRNSSecond Price Monitoring Extn
29th Jun 20204:35 pmRNSPrice Monitoring Extension
23rd Jun 20207:00 amRNSHong Kong Listing Update
8th Jun 202011:05 amRNSSecond Price Monitoring Extn
8th Jun 202011:00 amRNSPrice Monitoring Extension
30th Apr 20201:08 pmRNSConvertible Loan Extension
16th Apr 202010:31 amRNSResult of AGM
30th Mar 202011:56 amRNSResubmission of Hong Kong Listing Application
26th Mar 20201:53 pmRNSPosting of Circular and Notice of AGM
26th Mar 202012:56 pmRNSFinal Results
11th Feb 20207:00 amRNSTrading Update and Coronavirus Information
4th Feb 20202:05 pmRNSSecond Price Monitoring Extn
4th Feb 20202:00 pmRNSPrice Monitoring Extension
8th Jan 20207:00 amRNSHong Kong Listing Update
24th Oct 20198:36 amRNSDirector/PDMR Shareholding
23rd Oct 201910:35 amRNSResult of EGM
15th Oct 20192:05 pmRNSSecond Price Monitoring Extn
15th Oct 20192:00 pmRNSPrice Monitoring Extension
7th Oct 20197:00 amRNSDirector/PDMR Shareholding
3rd Oct 20194:35 pmRNSPrice Monitoring Extension
2nd Oct 20193:28 pmRNSPosting of Circular and Notice of EGM
27th Sep 20193:45 pmRNSHalf-year Report
5th Sep 20192:05 pmRNSSecond Price Monitoring Extn
5th Sep 20192:00 pmRNSPrice Monitoring Extension
3rd Sep 20194:41 pmRNSSecond Price Monitoring Extn
3rd Sep 20194:36 pmRNSPrice Monitoring Extension
29th Jul 201910:13 amRNSResult of AGM
26th Jul 20192:11 pmRNSDirector/PDMR Shareholding
23rd Jul 20194:11 pmRNSHolding(s) in Company
23rd Jul 20193:31 pmRNSHolding(s) in Company
22nd Jul 201911:20 amRNSDirector/PDMR Shareholding
28th Jun 20198:31 amRNSNotice of AGM
25th Jun 20197:00 amRNSUpdate re Listing
19th Jun 20195:59 pmRNSFinal Results
16th Apr 20197:00 amRNSDirector/PDMR Shareholding
15th Mar 20197:00 amRNSDirector's Dealing
21st Feb 20197:00 amRNSAppointment of Broker
8th Feb 20199:05 amRNSSecond Price Monitoring Extn
8th Feb 20199:00 amRNSPrice Monitoring Extension
4th Feb 20197:00 amRNSConvertible Loan Agreement
17th Dec 20184:39 pmRNSTrading Update
24th Sep 20187:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.